Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

QuidelOrtho Corporation - Common Stock (NQ:QDEL)

33.02 -1.62 (-4.66%)
Streaming Delayed Price Updated: 12:49 PM EDT, Apr 3, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about QuidelOrtho Corporation - Common Stock

< Previous 1 2
...
10 11 12 13 14 15 16 17 Next >
State of Delaware Selects Quidel for COVID-19 Testing Program at Schools
From Quidel Corporation
Via Business Wire
Quidel to Hold Fiscal Second Quarter 2021 Financial Results Conference Call on August 5th, 2021
From Quidel Corporation
Via Business Wire
Quidel Receives CE Mark for Savanna® Multiplex Molecular Analyzer and Respiratory Viral Panel
From Quidel Corporation
Via Business Wire
New Website Created by Quidel Corporation Provides Consumers With Information and Easy-to-Understand Answers Regarding Lyme Disease
From Quidel Corporation
Via Business Wire
Earnings Scheduled For May 6, 2021
Companies Reporting Before The Bell • ViacomCBS (NASDAQ:VIAC) is projected to report quarterly earnings at $1.22 per share on revenue of $7.30 billion. • Cohen... 
Via Benzinga
The Daily Biotech Pulse: Priority Review For Amgen's Asthma Treatment, Evaxion Reports Positive Skin Cancer Readout, Quidel Recalls Lyra COVID-19 Test
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 7) Ambrx Biopharma Inc. (NYSE:... 
Via Benzinga
Topics Product Recall
Exposures COVID-19 Legal Product Safety
Quidel Recalls Lyra COVID Diagnostic Test Due To Potential False Negative Results
Quidel Corporation (NASDAQ: QDEL) is recalling its Lyra COVID-19 Assay test due to a high risk of false-negative results in patients with high amounts of the virus... 
Via Benzinga
Topics Product Recall
Exposures COVID-19 Legal Product Safety
A Review Of The 1st Half Reveals Plenty Of Great Stocks At Reasonable Prices
When you look at the market in a granular way as we did today, you begin to see patterns and trends that aren't visible on the surface. 
Via Talk Markets
Why Quidel Shot 4% Higher Today
There might be a surge in demand for coronavirus testing kits in the very near future. 
Via The Motley Fool
Exposures COVID-19
Public Service Campaign From Quidel Corporation Directed Toward Heightening Awareness Among Summer Camps of the Dangers of Lyme Disease
From Quidel Corporation
Via Business Wire
10 Biggest Price Target Changes For Monday
Barclays raised the price target for Accenture plc (NYSE: 
Via Benzinga
With Lyme Disease on the Rise Nationwide, Quidel Corporation Urges Early Testing With Its Rapid Point-of-Care Test
From Quidel Corporation
Via Business Wire
5 Value Stocks To Watch In The Healthcare Sector
A value stock is traditionally defined in terms of how investors in the marketplace are valuing that company's future growth prospects. Low P/E multiples are good base indicators... 
Via Benzinga
Screening for Ben Graham Value Stocks
A look at value stocks, the type of value stocks that Benjamin Graham, the father of value investing and one of the greatest value investors of all time, would have been buying. 
Via Talk Markets
A Peek Into The Markets: US Stock Futures Edge Higher; Crude Oil Rises 1%
Pre-open movers U.S. stock futures traded slightly higher in early pre-market trade after the S&P 500 index surged to another record close in the previous session. Investors... 
Via Benzinga
Topics Stocks
Exposures Fossil Fuels US Equities
5 Stocks To Watch For June 14, 2021
Some of the stocks that may grab investor focus today are: Wall Street expects Motorcar Parts of America, Inc. (NASDAQ: MPAA) to report quarterly earnings at $0.64 per share on... 
Via Benzinga
Quidel Receives Amended Emergency Use Authorization for New Sofia® Q Rapid Antigen Test Device
From Quidel Corporation
Via Business Wire
Quidel to Present Virtually at Raymond James Human Health Innovation Conference 2021
From Quidel Corporation
Via Business Wire
How Long Will Fulgent Genetics Benefit From the Pandemic?
Genetic testing for the coronavirus is slowing. 
Via The Motley Fool
Exposures COVID-19
3 High-Growth Stocks That Could Soar
These companies have a lot of room for growth -- and they could take you for quite a ride. 
Via The Motley Fool
Quidel to Present Virtually at William Blair 41st Annual Growth Stock Conference
From Quidel Corporation
Via Business Wire
A Look Into Healthcare Sector Value Stocks
What are Value Stocks? A value stock traditionally has a lower price when compared to stock prices of companies in the same industry. This indicates that the company may be... 
Via Benzinga
Quidel’s QuickVue® At-Home OTC COVID-19 Test Now Available for Sale Through Amazon
From Quidel Corporation
Via Business Wire
Why Quidel Stock Jumped Today
Investors rewarded the stock for triple-digit growth, but the market remains unsure about the remainder of 2021. 
Via The Motley Fool
Exposures COVID-19
Quidel Corp (QDEL) Q1 2021 Earnings Call Transcript
QDEL earnings call for the period ending March 31, 2021. 
Via The Motley Fool
Topics Earnings
Exposures Financial
Quidel: Q1 Earnings Insights
Shares of Quidel (NASDAQ:QDEL) were flat in after-market trading after the company reported Q1 results. Quarterly Results Earnings per share increased 259.02% year over year to $4... 
Via Benzinga
Quidel Reports First Quarter 2021 Financial Results
From Quidel Corporation
Via Business Wire
Quidel Forms Retail Collaboration With Walgreens for Over-the-Counter Sale of QuickVue® At-Home OTC COVID-19 Tests
From Quidel Corporation
Via Business Wire
The Daily Biotech Pulse: Merck's Keytruda Snags Another FDA Approval, Moderna Slips On Revenue Miss, Chemocentryx Adcom
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 5) AbbVie Inc. (NYSE: ABBV)... 
Via Benzinga
Exposures Product Safety
The Daily Biotech Pulse: Athenex, NeoGenomics And Amryt In M&A Mix, European Nod For Roche's Cancer Immunotherapy, Earnings Deluge Continues
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 4) AbbVie Inc. (NYSE: ABBV)... 
Via Benzinga
< Previous 1 2
...
10 11 12 13 14 15 16 17 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.